Stock- Based Awards and Stock-Based Employee Compensation Expense | 3. Stock- Based Awards and Stock-Based Employee Compensation Expense Our stock-based awards include (i) stock options, (ii) restricted stock awards, some of which are subject to time-based vesting (“Restricted Stock”) and some of which are subject to performance-based vesting (“Performance Stock”), and (iii) restricted stock units, some of which are subject to time-based vesting (“RSUs”) and some of which are subject to performance-based vesting (“Performance RSUs”). As of March 31, 2017, the Company had 1,902,521 stock options outstanding, 1,140,125 non-vested Restricted Stock awards; 193,110 non-vested Performance Stock awards; 129,420 non-vested RSUs; 60,663 non-vested Performance RSUs and 1,589,653 shares of common stock available for grant. Stock Option Activity The following is a summary of all stock option transactions during the three months ended March 31, 2017: Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Yrs) Outstanding at December 31, 2016 1,960,279 $ 3.78 Granted at market price 30,750 $ 4.96 Cancelled or expired — $ — Exercised (88,508 ) $ 3.40 Outstanding at March 31, 2017 1,902,521 $ 3.82 3.73 Options exercisable at March 31, 2017 1,634,271 $ 3.81 2.84 At March 31, 2017, we had 1,103,459 stock options outstanding and 865,959 stock options exercisable with an exercise price lower than the market price of the Company’s common stock on that date. The aggregate intrinsic value of these stock options were each $1.9 million and $1.7 million, respectively. The Company had no excess tax benefit in the three month period ended March 31, 2017, related to the exercise of the 88,508 stock options. The Company recorded a $2 thousand excess tax benefit in the three month period ended March 31, 2016, related to the exercise of 19,812 stock options. Restricted Stock Activity The following is a summary of Restricted Stock activity during the three months ended March 31, 2017: Restricted Shares Weighted Average Fair Value Non-vested restricted stock at December 31, 2016 689,242 $ 3.94 Granted at market price 600,623 4.97 Vested (149,740 ) 3.72 Cancelled — — Non-vested restricted stock at March 31, 2017 1,140,125 $ 4.52 The Company recorded a $71 thousand excess tax benefit in the three month period ended March 31, 2017, related to the 149,740 Restricted Stock awards that vested. The Company recorded a $32 thousand excess tax benefit in the three month period ended March 31, 2016, related to 168,750 Restricted Stock awards that vested. Restricted Stock Unit Activity The following is a summary of all RSU activity during the three months ended March 31, 2017: Restricted Stock Units Weighted Average Fair Value Non-vested restricted stock units at December 31, 2016 158,086 $ 3.92 Granted at market price 54,500 4.96 Vested (83,166 ) 3.86 Cancelled — — Non-vested restricted stock units at March 31, 2017 129,420 $ 4.39 The Company recorded a $9 thousand excess tax benefit in the three month period ended March 31, 2017, related to the 83,166 RSUs that vested. The Company recorded a $5 thousand excess tax benefit in the three month period ended March 31, 2016, related to 133,664 RSUs that vested. Performance RSU Activity The following is a summary of all Performance RSU activity during the three months ended March 31, 2017: Performance RSUs Weighted Average Fair Value Non-vested performance RSUs at December 31, 2016 90,831 $ 3.81 Granted at market price 11,500 4.96 Vested — — Forfeited (41,668 ) 3.83 Non-vested performance RSUs at March 31, 2017 60,663 $ 4.02 The Company had no excess tax benefit in the three month period ended March 31, 2017. The Company recorded a $12 thousand excess tax benefit in the three month period ended March 31, 2016, related to 77,428 Performance RSUs that vested. Performance Stock Activity The following is a summary of all Performance Stock activity during the three months ended March 31, 2017: Performance Stock Weighted Average Fair Value Non-vested performance stock at December 31, 2016 121,500 $ 3.61 Granted at market price 112,112 4.96 Vested — — Forfeited (40,502 ) 3.61 Non-vested performance stock at March 31, 2017 193,110 $ 4.39 The Company had no excess tax benefit in each of the three month periods ended March 31, 2017, and 2016. The weighted average grant-date fair value of awards of Restricted Stock, RSUs, Performance RSUs and Performance Stock is based on the quoted market price of the Company’s common stock on the date of grant. Stock-Based Compensation Expense For the three month period ended March 31, 2017, the total stock-based employee compensation expense resulting from stock options, Restricted Stock, RSUs, Performance RSUs and Performance Stock was recorded to the following line items of the Company’s condensed consolidated statements of income: (In thousands) Three Months Ended March 31, 2017 Cost of revenues $ 71 Research and development 80 Selling, general and administrative 439 Stock-based compensation expense $ 590 A deferred tax asset totaling $172 thousand and $90 thousand, resulting from stock-based compensation expense associated with awards relating to the Company’s U.S. operations, was recorded for the three month periods ended March 31, 2017 and 2016, respectively. As of March 31, 2017, there was $6.6 million of total unrecognized stock-based compensation expense related to non-vested stock-based compensation awards granted under the incentive plans. This expense is expected to be recognized over a weighted average period of 1.80 years. For additional information regarding the Company’s Equity Awards and Stock-based Employee Compensation, see Note 3 to the consolidated financial statements contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016. |